The Global Chemiluminescence Immunoassay (CLIA) Analyzers Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Chemiluminescence immunoassay (CLIA) is an immunoassay technique where the label, i.e. the true “indicator” of the analytic reaction, is a luminescent molecule. CLIA instruments progressively infiltrated the immunometric assay domain, eventually being used to measure serum concentrations of hormones, drugs, vitamins, tumour markers, infectious disease markers, myocardial damage markers and, finally, autoantibodies. Today, autoantibody detection in immunochemiluminescence can be carried out on instruments specifically dedicated to the autoimmunology laboratory as stand-alone instrumentation or as part of an automated analytical platform.
Scope of the Report:
The worldwide market for Chemiluminescence Immunoassay (CLIA) Analyzers is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.
This report focuses on the Chemiluminescence Immunoassay (CLIA) Analyzers in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Siemens AG Healthcare
- BioMérieux
- Abbott Laboratories
- Johnson & Johnson
- Tosoh Corporation
- Randox Laboratories
- Ortho Clinical Diagnostics
- Sysmex Corporation
- iaSorin
- Beckman Coulter
- Danaher
- Hoffmann-La Roche
- Shenzhen New Industries Biomedical Engineering
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Reagents
- Consumables
- Analyzers
Market Segment by Applications, can be divided into
- Contract Research Organization
- Hospitals
- Pharmaceuticals
- Medical & Diagnostic Laboratories
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Chemiluminescence Immunoassay (CLIA) Analyzers product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Chemiluminescence Immunoassay (CLIA) Analyzers, with price, sales, revenue and global market share of Chemiluminescence Immunoassay (CLIA) Analyzers in 2017 and 2018.
Chapter 3, the Chemiluminescence Immunoassay (CLIA) Analyzers competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Chemiluminescence Immunoassay (CLIA) Analyzers breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Chemiluminescence Immunoassay (CLIA) Analyzers market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Chemiluminescence Immunoassay (CLIA) Analyzers sales channel, distributors, customers, research findings and conclusion, appendix and data source.